RAPT Q1 2023 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$32M

Net Income

-$29M

EPS (Diluted)

$-6.12

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$248M

Total Liabilities

$28M

Stockholders' Equity

$220M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$641,000	-100.0%
Gross Profit	$0	$641,000	-100.0%
Operating Income	-$32M	-$21M	-51.9%
Net Income	-$29M	-$20M	-43.0%